IPRASENSE is headquartered in Montpellier (France). The company is focused on the development and commercialization of innovative cell culture monitoring equipments from early biological research to biopharmaceutical industry and therapeutic molecule production.

IPRASENSE reinvents the automated cell counter and viability analyzers. Our unique label-free imaging technology provides extremely fast cell count and viability from a few μl sample volume of your cell suspension. The unmatched repeatability directly results from the extremely large field of view of the single analyzed image, together with the sample preparation free method (no dilution, no label like trypan blue).

Our strategy is based on early Research and Development efforts along with market knowledge to continuously launch breaking solutions products and services to our customers.

Projects & Research Partners

Finances & Supports Partners


FR3093107 : Procédé de caractérisation d’une particule à partir d’un hologramme.

FR3049348 : Procédé de caractérisation d’une particule dans un échantillon.

FR3029632 : Procédé d’obtention d’une image d’un échantillon, et système associé d’imagerie sans lentille.

FR3036801 : Sonde immergeable à site de mesure de taille variable.